You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 11, 2025

Suppliers and packagers for generic pharmaceutical drug: BENOXINATE HYDROCHLORIDE; FLUORESCEIN SODIUM


✉ Email this page to a colleague

« Back to Dashboard


BENOXINATE HYDROCHLORIDE; FLUORESCEIN SODIUM

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Altaire Pharms Inc ALTAFLUOR BENOX benoxinate hydrochloride; fluorescein sodium SOLUTION/DROPS;OPHTHALMIC 208582 NDA Altaire Pharmaceuticals Inc. 59390-218-05 5 mL in 1 BOTTLE, DROPPER (59390-218-05) 2018-03-01
Bausch Lomb Ireland FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE benoxinate hydrochloride; fluorescein sodium SOLUTION/DROPS;OPHTHALMIC 211039 NDA Bausch & Lomb Incorporated 24208-734-05 1 BOTTLE, GLASS in 1 CARTON (24208-734-05) / 5 mL in 1 BOTTLE, GLASS 2020-03-20
Bausch Lomb Ireland FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE benoxinate hydrochloride; fluorescein sodium SOLUTION/DROPS;OPHTHALMIC 211039 NDA AUTHORIZED GENERIC Oceanside Pharmaceuticals 68682-732-05 1 BOTTLE, GLASS in 1 CARTON (68682-732-05) / 5 mL in 1 BOTTLE, GLASS 2021-03-25
Bausch Lomb Ireland FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE benoxinate hydrochloride; fluorescein sodium SOLUTION/DROPS;OPHTHALMIC 211039 NDA AUTHORIZED GENERIC Bausch & Lomb Americas Inc. 82260-734-05 1 BOTTLE, GLASS in 1 CARTON (82260-734-05) / 5 mL in 1 BOTTLE, GLASS 2020-03-20
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drugs: Benoxinate Hydrochloride and Fluorescein Sodium

Last updated: July 29, 2025

Introduction

The pharmaceutical segment dedicated to ophthalmic drugs has seen notable growth driven by rising incidences of ocular diseases, expanding healthcare access, and technological innovations. Among the key agents used in diagnostic and anesthetic procedures are Benoxinate Hydrochloride and Fluorescein Sodium. Understanding the global supply landscape for these compounds is crucial for manufacturers, healthcare providers, and stakeholders seeking reliable sourcing, quality assurance, and strategic procurement insights.

This article investigates the leading suppliers of Benoxinate Hydrochloride and Fluorescein Sodium, analyzes their market positions, and explores factors influencing supply dynamics. The focus will be on global manufacturers, authorized suppliers, and emerging players, with an emphasis on their geographic presence, manufacturing capacity, regulatory compliance, and distribution channels.


Benoxinate Hydrochloride: An Overview of Supply Sources

Properties and Uses

Benoxinate Hydrochloride, also known by its trade names such as Benoxinate or Duralume, is a local anesthetic predominantly utilized for ocular surface anesthesia during ophthalmic procedures. It is often combined with fluorescein sodium for diagnostic purposes, such as tonometry and slit-lamp examinations, to enhance patient comfort and procedural accuracy.

Leading Suppliers and Manufacturers

1. Akorn, Inc.

  • Overview: Akorn is a prominent U.S.-based pharmaceutical firm specializing in sterile ophthalmic solutions and topical anesthetics.
  • Product Portfolio: Akorn supplies Benoxinate Hydrochloride in ophthalmic solution forms, adhering to strict U.S. FDA regulations.
  • Market Position: Recognized for high-quality manufacturing and extensive distribution networks, Akorn secures a significant share in North America and exports globally.

2. Alcon Laboratories

  • Overview: As a leading ophthalmic healthcare company, Alcon manufactures various ophthalmic anesthetics and diagnostic agents.
  • Product Portfolio: Although mainly known for specific ophthalmic drugs, Alcon sources Benoxinate from licensed producers for its diagnostic kits.
  • Supply Dynamics: Alcon's extensive global footprint ensures steady supply chains, backed by rigorous regulatory compliance.

3. SANTEN Pharmaceutical Co., Ltd.

  • Overview: A major Japanese pharmaceutical entity specializing in ophthalmic solutions and diagnostic agents.
  • Supply Role: SANTEN produces ophthalmic anesthetics and collaborates with global distributors, including Benoxinate formulations, for domestic and export markets.

4. Privately-Owned Manufacturers and Contract Manufacturers

  • Emerging Players: Several smaller, often regional, companies in India and China manufacture Benoxinate Hydrochloride, primarily serving local markets through licensed APIs and formulations.
  • Regulatory Status: These suppliers are typically regulated under respective national agencies (e.g., CDSCO in India, NMPA in China) with varying degrees of international regulatory approval.

Regulatory Considerations

The United States FDA, European Medicines Agency (EMA), and other regional authorities impose strict Good Manufacturing Practice (GMP) standards. Suppliers with such certifications are prioritized by global buyers for quality assurance and compliance.


Fluorescein Sodium: An Overview of Supply Sources

Properties and Uses

Fluorescein Sodium is an established diagnostic dye used extensively in ophthalmology for corneal abrasions, lens and retinal examinations, and fluorescein angiography. Its high demand stems from widespread diagnostic utility and the need for high-purity formulations.

Major Suppliers

1. Akorn, Inc.

  • Market Leadership: Akorn supplies sterile fluorescein sodium solutions widely used in clinical settings.
  • Distribution Channels: Their products are available globally, supported by a strong quality and regulatory compliance framework.

2. Akorn’s Competitors:

  • Bausch + Lomb: They produce ophthalmic diagnostic dyes, including fluorescein sodium, with global distribution networks.
  • Alcon: As with their anesthetics, Alcon offers ophthalmic diagnostic agents including fluorescein formulations.
  • Haag-Streit: Specializes in diagnostic ophthalmic devices and dyes, supplying high-quality fluorescein sodium.

3. Chinese and Indian Manufacturers

  • Emerging Supply Base: Several domestic manufacturers produce fluorescein sodium in bulk at lower costs, targeting regional markets.
  • Regulatory & Quality: Quality varies; however, increasing adoption of international GMP standards in these countries is improving product reliability.

4. Specialty Chemical Suppliers

  • Companies like Fisher Scientific, Sigma-Aldrich (a part of Merck Group), and Thermo Fisher Scientific provide high-purity fluorescein sodium to laboratories and hospitals worldwide.

Regulatory and Quality Standards

Global suppliers adhere to pharmacopeial standards, such as the United States Pharmacopeia (USP) and European Pharmacopeia, ensuring consistent purity, stability, and safety.


Supply Chain Dynamics and Market Trends

Globalization and Supply Security

The sourcing of ophthalmic agents like Benoxinate Hydrochloride and Fluorescein Sodium increasingly relies on international supply chains. While regions like North America and Europe dominate in high-quality, GMP-compliant manufacturing, emerging markets supply cost-effective options.

Impact of Regulatory Harmonization

Stringent regulations necessitate manufacturers to maintain compliance with GMP standards, influencing supply reliability. Suppliers with certified facilities enjoy better market access and tenders in regulated markets.

Manufacturing Consolidation and Outsourcing

Many pharmaceutical companies outsource manufacturing to Contract Manufacturing Organizations (CMOs), broadening the supplier base but also raising concerns about supply chain stability and quality.

Supply Chain Disruptions

Recent global events, such as the COVID-19 pandemic, have exposed vulnerabilities. Shortages of active pharmaceutical ingredients (APIs) and transportation delays impact the availability of these ophthalmic solution ingredients.


Conclusion

The supply landscape for Benoxinate Hydrochloride and Fluorescein Sodium features a mix of established global players and regional manufacturers. Leading global suppliers like Akorn, Alcon, and SANTEN ensure availability and compliance through rigorous quality standards, while emerging manufacturers serve regional needs with varied regulatory adherence. The reliance on international supply chains underscores the importance of regulatory compliance, quality assurance, and strategic procurement to mitigate disruptions.


Key Takeaways

  • Major global suppliers include Akorn, Alcon, and SANTEN, all maintaining GMP standards and broad distribution networks.
  • Regional manufacturers in India and China contribute significantly to local markets, often at lower costs but with varying quality compliance.
  • Ensuring regulatory adherence and quality assurance remains vital for supply stability and patient safety.
  • Global supply chain disruptions necessitate diversified sourcing strategies and closer regulatory oversight.
  • The ongoing trend toward regulatory harmonization and quality certifications enhances supply security.

FAQs

  1. Who are the leading international manufacturers of Benoxinate Hydrochloride?
    Akorn, Alcon, and SANTEN are among the most recognized global producers, offering GMP-certified ophthalmic anesthetic solutions.

  2. Are regional manufacturers reliable sources for Fluorescein Sodium?
    Many regional manufacturers in India and China supply fluorescein sodium with varying quality standards. Buyers should verify GMP certification and quality documentation before procurement.

  3. What regulations govern the supply of ophthalmic drugs like these?
    Regulatory authorities such as the FDA (U.S.), EMA (Europe), and CDSCO (India) govern manufacturing and distribution under GMP and pharmacopeial compliance.

  4. How has recent supply chain disruption affected the availability of these drugs?
    Disruptions in manufacturing and logistics have occasionally led to shortages, emphasizing the importance of diversified sourcing and inventory planning.

  5. What qualities should buyers look for in suppliers of these ophthalmic agents?
    Certifications (GMP, ISO), consistent quality, robust distribution channels, regulatory approvals, and transparency in manufacturing practices are critical considerations.


Sources

  1. [1] Akorn Pharmaceuticals. Product Portfolio and Market Presence.
  2. [2] Alcon Laboratories. Ophthalmic Solutions and Diagnostic Agents.
  3. [3] SANTEN Pharmaceutical. ophthalmic drug manufacturing and distribution.
  4. [4] U.S. Food and Drug Administration (FDA). Good Manufacturing Practice Regulations (21 CFR Parts 210 and 211).
  5. [5] European Medicines Agency (EMA). Guidelines for Ophthalmic Medical Devices and Drugs.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing